Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey

INTRODUCTION: This study aims to evaluate the cost-effectiveness of remdesivir compared to other existing therapies (SoC) in Turkey to treat COVID-19 patients hospitalized with < 94% saturation and low-flow oxygen therapy (LFOT) requirement. METHODS: We compared remdesivir as the treatment for CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Oksuz, Ergun, Malhan, Simten, Gonen, Mustafa Sait, Kutlubay, Zekayi, Keskindemirci, Yilmaz, Jarrett, James, Sahin, Toros, Ozcagli, Gokcem, Bilgic, Ahmet, Bibilik, Merve Ozlem, Tabak, Fehmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355577/
https://www.ncbi.nlm.nih.gov/pubmed/34379304
http://dx.doi.org/10.1007/s12325-021-01874-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355577/
https://www.ncbi.nlm.nih.gov/pubmed/34379304
http://dx.doi.org/10.1007/s12325-021-01874-9

Ejemplares similares